NCT05720702View on ClinicalTrials.gov

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

August 23, 2024

Study Completion Date

August 23, 2024

Conditions

NAFLD

Interventions

DIETARY_SUPPLEMENT

homocysteine (Hcy) lowering supplements

NAFLD participants will take homocysteine (Hcy) lowering supplements daily for 12 weeks.

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT05720702 - A Feasibility Trial of OCM Supplements for the Treatment of NAFLD | Biotech Hunter | Biotech Hunter